potassium channel inhibitors (Metrion Biosciences)

N/A

Report date: 2025/03/20 09:29:17
NME

Base Information

Drug Namepotassium channel inhibitors (Metrion Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsNerve DegenerationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetrion Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A